Back to Search
Start Over
Vemurafenib as bridging therapy of hairy cell leukemia in a Jehovah's Witness patient.
- Source :
-
Annals of hematology [Ann Hematol] 2022 Jan; Vol. 101 (1), pp. 217-218. Date of Electronic Publication: 2021 Jan 12. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1432-0584
- Volume :
- 101
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Annals of hematology
- Publication Type :
- Report
- Accession number :
- 33438048
- Full Text :
- https://doi.org/10.1007/s00277-021-04403-4